James Keith Cooley v. J.M. Smith Corporation

205 So. 3d 1167, 2016 Miss. App. LEXIS 402
CourtCourt of Appeals of Mississippi
DecidedJune 21, 2016
Docket2015-CA-00398-COA
StatusPublished
Cited by1 cases

This text of 205 So. 3d 1167 (James Keith Cooley v. J.M. Smith Corporation) is published on Counsel Stack Legal Research, covering Court of Appeals of Mississippi primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
James Keith Cooley v. J.M. Smith Corporation, 205 So. 3d 1167, 2016 Miss. App. LEXIS 402 (Mich. Ct. App. 2016).

Opinion

CARLTON, J.,

for the Court:

¶ 1. James Cooley (Cooley), on behalf of himself and Cooley Drug Inc. (Cooley Drug), appeals the Wayne County Circuit Court’s judgment granting J.M. Smith Corporation d/b/a Smith Drug Co. (Smith Drug) a replevin and contractual damages. On appeal, Cooley raises the following issues: (1) whether the circuit court erred by allowing Smith Drug to present evidence of contractual damages at the re-plevin hearing; and (2) whether the circuit court erred by awarding Smith Drug contractual damages. Finding no error, we affirm.

FACTS

¶2. On May 4, 2006, Cooley, as the principal of Cooley Drug, executed an “Application for Credit,” a “Continuing Guaranty of Payment,” and a “Security Agreement” with Smith Drug. Under the terms of the security agreement, Cooley Drug paid for inventory, which Smith Drug then shipped to Cooley Drug. Cooley guaranteed his company’s financial obligation for the inventory, and Smith Drug retained a security interest in certain specified collateral, including the inventory it shipped to Cooley Drug. The parties’ security agreement required Cooley Drug to “keep all of [the] collateral at its principle place of business unless and until such collateral is *1169 disposed of in the ordinary course of [Cooley Drug’s] business.” If Cooley defaulted on his payments or in the performance of his obligations and forced Smith Drug to institute legal proceedings or hire an attorney, Cooley agreed to pay all costs for the collection of the collateral, including Smith Drug’s reasonable attorney’s fees.

¶3. After executing their agreement, Smith Drug shipped Cooley Drug inventory valued at $141,148.57. However, Cooley Drug defaulted on its payment obligation to Smith Drug. Therefore, on January 28, 2013, Smith Drug filed a complaint against Cooley and Cooley Drug for a replevin and damages. Smith Drug attached the parties’ “Application for Credit,” “Continuing Guaranty of Payment,” and “Security Agreement” to its complaint. The complaint requested that the circuit court award Smith Drug immediate possession of the collateral at issue or, in the alternative, the proceeds of the collateral. In addition, Smith Drug requested attorney’s fees as provided in the parties’ agreement.

¶ 4. Cooley neither filed an answer to Smith Drug’s complaint nor responded to Smith Drug’s requests for admission. Instead, on March 15, 2013, Cooley filed a motion to dismiss Smith Drug’s complaint, and Smith Drug filed a timely response. Although Cooley’s motion to dismiss was never formally set for a hearing, the circuit court heard the motion to dismiss when it heard Cooley’s motion for a new trial. On September 30, 2013, the circuit court entered an order setting the trial for November 20, 2013, on Smith Drug’s request for a writ of replevin. Also on September 30, 2013, the circuit court entered a fiat directing that Cooley appear on the trial date to answer Smith Drug’s complaint and for “a final hearing to determine the rights of the parties ... as to the property described in the [c]omplaint[.]”

¶ 5. At the hearing on November 20, 2013, Smith Drug’s attorney informed the circuit court of Cooley’s failure to respond to Smith Drug’s requests for admission. Specifically, Smith Drug sought to admit evidence as to the value of the collateral at issue. Due to Cooley’s failure to answer the complaint and to respond to discovery requests for admission, the circuit court deemed the value of the collateral admitted.

¶ 6. During the hearing, the only witness called by either of the parties was Smith Drug’s corporate representative, Tony Thompson. Thompson testified that he visited Cooley Drug’s premises the morning of the trial. Although Cooley Drug’s front door was padlocked, Thompson testified that he could see into the store. Based on his observations, Thompson testified that Cooley Drug’s shelves appeared almost empty and that the building appeared to hold no inventory. Thompson also testified that he possessed no information to indicate that any of Smith Drug’s inventory remained -within the building. Thompson confirmed that, as of November 15, 2013, Cooley Drug owed Smith Drug $141,148.57 for the inventory Smith Drug shipped to Cooley Drug. During Thompson’s testimony, Smith Drug established the value of its security interest in the collateral by offering into evidence several documents, including its Uniform Commercial Code filing statement and the parties’ security agreement. After Thompson’s testimony, Smith Drug rested, and Cooley elected not to call any witnesses.

¶ 7. Following the trial, the circuit court entered a judgment awarding Smith Drug a replevin and contractual damages. Finding that Smith Drug retained an interest in the collateral, the circuit court granted Smith Drug immediate possession of and ownership over any collateral that might be found. However, the circuit *1170 court also determined that Cooley Drug no longer had possession of or control over the collateral and that no proof existed that any of the collateral remained. Thus, the circuit court awarded Smith Drug $141,148.57, which constituted the value of the unrecovered collateral. Pursuant to the parties’ security agreement, the circuit court also awarded Smith Drug $11,396 in attorney’s fees.

¶8. Following the circuit court’s judgment, Cooley filed an unsuccessful motion for a new trial. Aggrieved by the circuit court’s judgment and the denial of his new-trial motion, Cooley appeals.

STANDARD OF REVIEW

¶ 9. As this Court has previously acknowledged:

An appellate court, when reviewing the decision of a trial judge sitting without a jury, may only reverse when the findings of the trial judge are manifestly wrong or clearly erroneous. Further, a circuit court judge’s findings are safe on appeal where they are supported by substantial, credible, and reasonable evidence.

Hammond v. Caterpillar Fin. Servs. Corp., 66 So.3d 700, 701 (¶ 6) (Miss.Ct.App.2011) (internal citations and quotation marks omitted).

DISCUSSION

I. Whether the circuit court erred by allowing Smith Drug to present evidence of contractual damages at the replevin hearing.

II. Whether the circuit court erred by awarding Smith Drug contractual damages.

¶ 10. We address Cooley’s two assignments of error together. According to Cooley, Smith Drug sought a hearing only on a replevin. Cooley therefore asserts that he prepared for a hearing only on a replevin and not on the additional issue of contractual damages. Arguing that the circuit court should have limited the hearing to the issue of a replevin, Cooley contends that the circuit court erred by allowing Smith Drug to also present evidence of contractual damages and by awarding Smith Drug a judgment of $141,148.57 for damages. Cooley asserts that the circuit court should have instead determined whether a replevin was appropriate and then, if necessary, conducted a separate hearing to determine a damages award.

¶ 11. Replevin is a statutorily governed action. Lacoste v. Sys. & Servs. Techs. Inc., 126 So.3d 111, 112 (¶ 1) (Miss.Ct.App. 2013). “Mississippi’s replevin statute gives would-be possessors two procedural options];.]” Id.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Delando Wilson v. City of Greenville
Court of Appeals of Mississippi, 2022

Cite This Page — Counsel Stack

Bluebook (online)
205 So. 3d 1167, 2016 Miss. App. LEXIS 402, Counsel Stack Legal Research, https://law.counselstack.com/opinion/james-keith-cooley-v-jm-smith-corporation-missctapp-2016.